期刊文献+

萘普生在介孔分子筛MCM-41中的负载及其溶出性能

Dissolution of Naproxen in Mesoporous Molecular Sieve MCM-41
下载PDF
导出
摘要 用含氨基的偶联剂修饰介孔分子筛MCM-41的表面,将修饰前和修饰后的介孔分子筛分别负载难溶性药物萘普生(NAP),利用X射线衍射、傅里叶变换红外光谱、差示扫描量热分析、扫描电子显微镜、透射电子显微镜和N2吸附-脱附分析等技术分别对其进行了结构表征和性能测试。结果表明,药物分子存在于分子筛的孔道中。负载在MCM-41中的萘普生溶出速率远优于原料药,60 min时大约溶出70%。氨基修饰后的药物释放速率比修饰前有所减慢,表明可通过氨基修饰调节释放速率。 The poorly-water soluble drug naproxen(NAP) was loaded on modified and unmodified mesoporous molecular sieves MCM-41.The drug-loaded samples were characterized by X-ray diffraction(XRD),Fourier transform infrared spectroscopy(FT-IR),differential scanning caborimetry(DSC),scanning electron microscopy(SEM) analysis,transmission electron microscopy(TEM) analysis,nitrogen adsorption/desorption isotherms,respectively.The results showed that the hexagonal mesoporous structure was still remained after loading with drug molecules,which were entrapped inside the mesopores.The dissolution rate of NAP released from mesoporous molecular sieves MCM-41 was faster compared with the dissolution rate of pure NAP.In simulated intestinal fluid,the MCM-41-NAP and MCM-41-NH2-NAP exhibited 70% mass fraction burst release within 60 min.Remarkably,the dissolution rate of NAP released from all mesoporous materials is faster compared with the dissolution rate of pure NAP.At the same time,the release rate of NAP from the functionalized mesoporous materials was effectively controlled compared with that of the unmodified materials.
出处 《应用化学》 CAS CSCD 北大核心 2012年第11期1272-1277,共6页 Chinese Journal of Applied Chemistry
基金 沈阳市人才资助项目(210114)
关键词 分子筛 修饰 溶出 萘普生 molecular sieves MCM-41 modification enhanced dissolution naproxen
  • 相关文献

参考文献16

  • 1Pinnamaneni S, Das N G, Das S K. Formulation Approaches Fororally Administered Poorly Soluble Drug[ J]. Pharmazie, 2002 ,57 (5) :291-300.
  • 2孙淑英,房芳,逄秀娟,闫宏林,贾立革,赫春英.萘普生缓释片及人体药代动力学研究[J].沈阳药科大学学报,1997,14(1):1-4. 被引量:2
  • 3Davis M E. Ordered Porous Materials for Emerging Applications[J]. Nature,2002,417(6891):813-821.
  • 4Chen H R, Shi J L, Li Y S. A New Method for the Synthesis of Highly Dispersive and Catalytically Active Platinum Nanoparticles Confined in Mesoporous Zirconia[J]. Adv Mater,2003,15(13) : 1078-1081.
  • 5Liu R,Zhang Y,Zhao X,et al. pH-Responsive Nanogated Ensemble Based on Gold-Capped Mesoporous Silica through an Acid-Labile Acetal Linker[ J ]. J Am Chem Soc ,2010,132 (5) : 1500-1501.
  • 6钟国英,王秀芳,林汉森.新型有序介孔材料在药物传递系统中的应用[J].材料导报,2010,24(19):71-74. 被引量:1
  • 7Slowing H, Trewyn B G, Girl S,et al. Mesoporous Silica Nanoparticles for Drug Delivery and Biosensing Applications [ J ]. Adv Funct Mater, 2007,17 ( 8 ) : 1225-1226.
  • 8袁丽,王蓓娣,唐倩倩,张晓鸿,张晓环,杨东,胡建华.介孔二氧化硅纳米粒子应用于可控药物传输系统的若干新进展[J].有机化学,2010,30(5):640-647. 被引量:25
  • 9Andersson J, Rosenholm J, Areva S, et al. Influences of Material Characteristics on Ibuprofen Drug Loading and Release Profiles from Ordered Micro-and Mesoporous Silica Matrices[J]. Chem Mater,2004,16(21 ) :4160-4167.
  • 10Doadrio A L, Sousa E M B, Doadrio J C, et al. Mesoporous SBA-15 HPLC Evaluation for Controlled Gentamicin Drug Delivery[J]. J Controlled Release ,2004,97( 1 ) : 125-132.

二级参考文献57

共引文献49

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部